Conference Coverage
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris sit amet vulputate enim, ut finibus felis. Cras id mattis elit. Etiam mauris enim, congue quis nisl nec, aliquet blandit enim.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris sit amet vulputate enim, ut finibus felis. Cras id mattis elit. Etiam mauris enim, congue quis nisl nec, aliquet blandit enim.